KR880005077A - 우울증 억제제로서 1-벤질-아미노알킬-피롤리디논의 용도 - Google Patents

우울증 억제제로서 1-벤질-아미노알킬-피롤리디논의 용도 Download PDF

Info

Publication number
KR880005077A
KR880005077A KR870011159A KR870011159A KR880005077A KR 880005077 A KR880005077 A KR 880005077A KR 870011159 A KR870011159 A KR 870011159A KR 870011159 A KR870011159 A KR 870011159A KR 880005077 A KR880005077 A KR 880005077A
Authority
KR
South Korea
Prior art keywords
group
alkyl group
substituted
alkyl
benzyl
Prior art date
Application number
KR870011159A
Other languages
English (en)
Other versions
KR950009091B1 (en
Inventor
레어 에리히
베크텔 볼트-디트리히
뵈케-쿤 카린
슈나이더 클라우스
발테어 게르하르트
베버 칼-하인쯔
Original Assignee
디터 라우디엔, 루돌프 호프만
베링거 인겔하임 케이지
루돌프 호프만
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디터 라우디엔, 루돌프 호프만, 베링거 인겔하임 케이지, 루돌프 호프만 filed Critical 디터 라우디엔, 루돌프 호프만
Publication of KR880005077A publication Critical patent/KR880005077A/ko
Application granted granted Critical
Publication of KR950009091B1 publication Critical patent/KR950009091B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

내용 없음

Description

우울증 억제제로서 1-벤질-아미노알킬-피롤리디논의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 일반식(Ⅰ)의 화합물 및 이의 약물학적으로 허용된는 산부가염의 우울증 억제제로서의 용도.
    상기식에서 R1은 수소 또는 알킬그룹을 나타내고, R2는 알콕시, 불소, 염소, 브롬, 트리플루오로메틸, 알킬, 하이드록시 또는 니트로에 의해 일-또는 이치환 될수 있는 페닐그룹을 나타내거나 피리딜그룹을 나타내며, R3는 수소 또는 알킬그룹을 나타내고, R4는 수소 또는 알킬그룹을 나타낼 수 있거나, R3및 R4두그룹이 질소원자와 함께, 추가로 헤테로원자로서 O 또는 N 원자를 함유할 수 있고 메틸에 의해 임으로 치환될 수 있거나 이미다졸 환을 형성할수 있는 포환된 5- 또는 6-원 환을 나타낼수 있으며, 한편 아미노알킬그룹은 4 또는 5위치에 존재한다.
  2. 1-벤질-4-아미노메틸-피롤리딘-2-온 및 임의적인 이의 약물학적으로 허용되는 산부가염의 우울증억제제로서의 용도.
  3. 우울증 치료하는 약학적 조성물을 제조하기 위한 일반식(Ⅰ) 화합물의 용도.
    상기식에서 R1은 수소 또는 알킬그룹을 나타내고, R2는 알콕시, 불소, 염소, 브롬, 트리플루오로메틸, 알킬, 하이드록시 또는 니트로에 의해 일-또는 이치환 될수 있는 페닐그룹을 나타내거나 피리딜그룹을 나타내며, R3는 수소 또는 알킬그룹을 나타내고, R4는 수소 또는 알킬그룹을 나타낼 수 있거나, R3및 R4두그룹이 질소원자와 함께, 추가로 헤테로 원자로서 O 또는 N 원자를 함유할 수 있고 메틸에 의해 임의로 치환될 수 있거나 이미다졸 환을 형성할수 있는 포화된 5- 또는 6-원 환을 나타낼수 있으며, 한편 아미노알킬그룹은 4 또는 5위치에 존재한다.
  4. 우울증을 치료하는 약학적 조성물을 제조하기 위한 1-벤질-4-아미노메틸-피롤리딘-2-온 및 임의적인 이의 약물학적으로 허용되는 산부가염의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR87011159A 1986-10-08 1987-10-06 Antidepressants containing 1-benzyl-aminoalkyl-pyrrolidinones KR950009091B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863634220 DE3634220A1 (de) 1986-10-08 1986-10-08 Verwendung von 1-benzyl-aminoalkyl-pyrrolidinonen als antidepressiva
DEP3634220.3 1986-10-08

Publications (2)

Publication Number Publication Date
KR880005077A true KR880005077A (ko) 1988-06-27
KR950009091B1 KR950009091B1 (en) 1995-08-14

Family

ID=6311269

Family Applications (1)

Application Number Title Priority Date Filing Date
KR87011159A KR950009091B1 (en) 1986-10-08 1987-10-06 Antidepressants containing 1-benzyl-aminoalkyl-pyrrolidinones

Country Status (8)

Country Link
US (3) US4812453A (ko)
EP (1) EP0266563B1 (ko)
JP (1) JPH0737382B2 (ko)
KR (1) KR950009091B1 (ko)
AT (1) ATE72112T1 (ko)
DE (2) DE3634220A1 (ko)
IE (1) IE60263B1 (ko)
PH (1) PH25506A (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4638333A (en) * 1985-10-25 1987-01-20 Xerox Corporation Thermal printing circuit
FR2696744B1 (fr) * 1992-10-12 1994-12-30 Logeais Labor Jacques Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
IE60263B1 (en) 1994-06-29
US4912129A (en) 1990-03-27
PH25506A (en) 1991-07-24
JPS6396125A (ja) 1988-04-27
IE872676L (en) 1988-04-08
US4954516A (en) 1990-09-04
EP0266563A2 (de) 1988-05-11
EP0266563B1 (de) 1992-01-29
DE3634220A1 (de) 1988-04-14
KR950009091B1 (en) 1995-08-14
JPH0737382B2 (ja) 1995-04-26
DE3776488D1 (ko) 1992-03-12
US4812453A (en) 1989-03-14
EP0266563A3 (en) 1990-06-13
ATE72112T1 (de) 1992-02-15

Similar Documents

Publication Publication Date Title
DK38982A (da) Fremgangsmaade til fremstilling af 2-penemforbindelser
MX5680E (es) Procedimiento para la preparacion de 2-(2-alcoxietil)-2'-hidroxi-6,7-benzomorfanos
IT1171880B (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione
IT1152287B (it) Pirrolidin-derivati
RU92016545A (ru) Гетероциклические соединения, способ их получения и фармацевтическая композиция
KR900006296A (ko) 이미다졸린 유도체 및 그의 제조방법
KR960007592A (ko) 신규한 피롤로카바졸
KR890000482A (ko) (8β)-1-알킬-6-(치환된) 에르 골린의 시클로알킬아미드
SE8006365L (sv) Cyklohexankarboxylsyraderivat
DK138488A (da) Imidazolderivater
KR900701716A (ko) 치환된 β-디 케톤류
DK435583A (da) Fremgangsmaade til fremstilling af heterocykliske derivater af cyklobutan
KR880005077A (ko) 우울증 억제제로서 1-벤질-아미노알킬-피롤리디논의 용도
KR890002079A (ko) 1-[2-(페닐메틸)페닐]피페라진 및 그의 제조방법
KR870004038A (ko) 제초제 화합물의 제조방법
KR910000141A (ko) 이소옥사졸린-3-온 유도체의 항울제로서의 용도
KR880009647A (ko) 우울증 치료 활성을 갖는 제제
KR910021373A (ko) 1-페녹시카보닐-2-피롤리디논 유도체 및 향정신성 약제
SE7903297L (sv) Beta-laktam-foreningar
MC1555A1 (fr) Dérivés de l'acridanone
DK601883D0 (da) Phenyl-propanolderivater
ATE333870T1 (de) Blockade der natriumkanäle durch phenolderivate
KR870004005A (ko) 5-나프틸-2,4-디알킬-3h-1,2,4-트리아졸-3-티온 및 이의 제조 방법
KR910000598A (ko) 아미노메틸페놀 및 이들 화합물을 함유하는 살균제
DK128892A (da) Benzyletherderivater

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20020725

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee